Abstract: Objective: Evaluate outcomes of Veterans who discontinued treatment with at least moderate ongoing depressive symptoms. Method: Veterans with elevated depression symptoms from 29 Department of Veterans Affairs facilities completed baseline surveys and follow-up assessments for one year. Analyses examined rates and predictors of treatment discontinuation, treatment re-engagement, and subsequent symptoms among patients who remained out of care. Results: A total of 242 (17.8%; n = 1359) Participants discontinued treatment while symptomatic, with Black Participants, Participants with less severe depression, and Participants receiving only psychotherapy (versus combined psychotherapy and antidepressant medications) discontinuing at higher rates. Among all Participants who discontinued treatment (n = 445), 45.8% re-engaged within the following six months with Participants receiving combined treatment re-engaging at higher rates. Of Participants who discontinued while symptomatic within the first 6 months of the study and did not return to care (n = 112), 68.8% remained symptomatic at 12 months. Lower baseline treatment expectancy and greater depression symptom severity were associated with remaining symptomatic while untreated. Conclusions: Black race, lower symptom severity, and treatment modality may help identify patients at higher risk for discontinuing care while symptomatic, whereas patients with lower treatment expectations may be at greater risk for remaining out of care despite continuing symptoms.